Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F5G0Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,235
Award facts
- Contract value 100% obligated
- $13,234.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,234.61 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of February 3, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant medication used in the treatment of plaque psoriasis and other inflammatory conditions, representing one of many pharmaceutical products distributed through AmerisourceBergen's federal supply network.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract was competitively awarded on a full and open basis, demonstrating Cencora's capability to meet federal procurement requirements for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F5G0Y?
SPE2DR26F5G0Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26F5G0Y worth?
The government has obligated $13,235 on SPE2DR26F5G0Y.
Is contract SPE2DR26F5G0Y an order under another contract?
Yes. SPE2DR26F5G0Y is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5G0Y competed?
The extent of competition for SPE2DR26F5G0Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award